These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 8610052)

  • 1. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
    Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.
    Gao X; Zacharek A; Salkowski A; Grignon DJ; Sakr W; Porter AT; Honn KV
    Cancer Res; 1995 Mar; 55(5):1002-5. PubMed ID: 7866981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer.
    Massenkeil G; Oberhuber H; Hailemariam S; Sulser T; Diener PA; Bannwart F; Schäfer R; Schwarte-Waldhoff I
    Anticancer Res; 1994; 14(6B):2785-90. PubMed ID: 7872719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.
    Gao X; Zacharek A; Grignon DJ; Sakr W; Powell IJ; Porter AT; Honn KV
    Oncogene; 1995 Oct; 11(7):1241-7. PubMed ID: 7478543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
    Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
    Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D
    Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer.
    Lu T; Hano H
    Prostate Cancer Prostatic Dis; 2008; 11(4):357-61. PubMed ID: 18227855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
    Vocke CD; Pozzatti RO; Bostwick DG; Florence CD; Jennings SB; Strup SE; Duray PH; Liotta LA; Emmert-Buck MR; Linehan WM
    Cancer Res; 1996 May; 56(10):2411-6. PubMed ID: 8625320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
    Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
    Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
    Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
    Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic changes associated with ovarian cancer.
    Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
    Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.
    Trybus TM; Burgess AC; Wojno KJ; Glover TW; Macoska JA
    Cancer Res; 1996 May; 56(10):2263-7. PubMed ID: 8625295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of the chromosomal region 10q23-25 in prostate cancer.
    Gray IC; Phillips SM; Lee SJ; Neoptolemos JP; Weissenbach J; Spurr NK
    Cancer Res; 1995 Nov; 55(21):4800-3. PubMed ID: 7585509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.